Library — CHDR

Search

Filter

Alternative trial design in amyotrophic lateral sclerosis saves time and patients.

Groeneveld GJ, Graf M, van der Tweel I, van den Berg LH, Ludolph AC

Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2007 Sep; 8(5):266-9

View publication
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.

Trenité DG, French JA, Hirsch E, Macher JP, Meyer BU, Grosse PA, Abou-Khalil BW, Rosenfeld WE, van Gerven J, Novak GP, Parmeggiani L, Schmidt B, Gibson D, Guerrini R

Epilepsy research, 2007 Apr; 74(2-3):193-200

View publication
Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis.

Veldink JH, Kalmijn S, Groeneveld GJ, Wunderink W, Koster A, de Vries JH, van der Luyt J, Wokke JH, Van den Berg LH

Journal of neurology, neurosurgery, and psychiatry, 2007 Mar; 78(4):367-71

View publication
Available treatment options for the management of Lambert-Eaton myasthenic syndrome.

Verschuuren JJ, Wirtz PW, Titulaer MJ, Willems LN, van Gerven J

Expert opinion on pharmacotherapy, 2006 Jun; 7(10):1323-36

View publication
Lack of association between VEGF polymorphisms and ALS in a Dutch population.

Van Vught PW, Sutedja NA, Veldink JH, Koeleman BP, Groeneveld GJ, Wijmenga C, Uitdehaag BM, de Jong JM, Baas F, Wokke JH, Van den Berg LH

Neurology, 2005 Nov; 65(10):1643-5

View publication
SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.

Veldink JH, Kalmijn S, Van der Hout AH, Lemmink HH, Groeneveld GJ, Lummen C, Scheffer H, Wokke JH, Van den Berg LH

Neurology, 2005 Sep; 65(6):820-5

View publication
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693.

van der Post JP, de Visser SJ, de Kam ML, Woelfler M, Hilt DC, Vornov J, Burak ES, Bortey E, Slusher BS, Limsakun T, Cohen AF, van Gerven JM

British journal of clinical pharmacology, 2005 Jul; 60(2):128-36

View publication
Few adverse effects of long-term creatine supplementation in a placebo-controlled trial.

Groeneveld GJ, Beijer C, Veldink JH, Kalmijn S, Wokke JH, van den Berg LH

International journal of sports medicine, 2005 Apr; 26(4):307-13

View publication
Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.

van Kan HJ, Groeneveld GJ, Kalmijn S, Spieksma M, van den Berg LH, Guchelaar HJ

British journal of clinical pharmacology, 2005 Feb; 59(3):310-3

View publication

«
1
2
...
9
10
11
12
13
14
15
...
18
19
»